What insurance policy changes affect HCPCS C1721?

There are 13 tracked policy changes affecting HCPCS C1721, including updates from Humana, Independence Blue Cross, Indiana Medicaid (IHCP). Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for HCPCS C1721?

Payers that have issued tracked updates for HCPCS C1721 include: Humana, Independence Blue Cross, Indiana Medicaid (IHCP).

How do I get notified when HCPCS C1721 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to HCPCS C1721. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for HCPCS C1721?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

C1721 — Cardioverter-defibrillator, dual chamber (implantable): Insurance Policy Changes

C1721 Insurance Policy Changes

HCPCS C1721 is officially defined as "Cardioverter-defibrillator, dual chamber (implantable)." HCPCS C1721 is referenced in 13 tracked payer policy changes from Humana, Independence Blue Cross, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C1721 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Cardioverter Defibrillators/Cardiac Resynchronization Therapy - Medicare Advantage (Revised)

Humana·Effective Aug 3, 2026

This is a revised Medicare Advantage policy for Cardioverter Defibrillators and Cardiac Resynchronization Therapy devices, effective August 3, 2026. The policy clarifies coverage for implantable devices (TV-ICD, S-ICD, EV-ICD), CRT devices, and external wearable defibrillators, and references specific CMS National Coverage Determinations and Local Coverage Determinations by geographic MAC jurisdiction. Billing teams must ensure claims align with the appropriate MAC's LCD based on patient location and device type.

C1721 Insurance Policy Changes

Cardiac Devices - MEDICAID - VIRGINIA (Revised)

Cardiac Devices - MEDICAID - INDIANA (Revised)

05.00.77g, Implantable Cardioverter Defibrillators

BT2026148: IHCP corrects pricing method for certain procedure codes

Cardiac Devices - MEDICAID - VIRGINIA (Revised)

Cardioverter Defibrillators/Cardiac Resynchronization Therapy - Medicare Advantage (Revised)

Cardioverter Defibrillators/Cardiac Resynchronization Therapy - Medicare Advantage (Revised)

05.00.77f, Implantable Cardioverter Defibrillators

05.00.77f, Implantable Cardioverter Defibrillators

Cardiac Devices - MEDICAID - INDIANA (New)

Cardiac Devices - MEDICAID - MICHIGAN (New)

Cardiac Devices - MEDICAID - OHIO (New)

Cardiac Devices - MEDICAID - SOUTH CAROLINA (Revised)